Connect with us

JAMMU & KASHMIR

Blood pressure medicines don’t increase risk of COVID: DAK | KNO

Published

on

kno news

Srinagar, June 01 (KNO): Doctors Association Kashmir (DAK) on Monday said blood pressure medicines do not increase the risk of infection, serious illness or death from the novel coronavirus. “It is perfectly safe to continue your blood pressure medication during the Covid pandemic,” said DAK President Dr Nisar-u-Hassan in a statement issued to news agency—Kashmir News Observer (KNO) “People have apprehensions that ACE inhibitors and ARBs, two classes of drugs that are widely prescribed for high blood pressure increase the risk of Covid infection and the likelihood of severe illness among those infected with the novel virus,” he said. “ACE inhibitors include enalapril, lisinopril, captopril and other drugs with generic names ending in –pril; ARBs include Losartan, telmisartan, olmesartan and other generic drugs ending in –sartan,” he added. Dr Nisar said speculations about worse outcomes among patients on these medications during the Covid pandemic have caused widespread anxiety among patients and their care providers. Quoting three studies published in New England Journal of Medicine, Dr Nisar said no link was found between the use of blood pressure drugs and coronavirus infection. “It was also revealed that patients on these drugs faced no increase in risk of becoming severely ill with Covid infection,” he added. Dr Nisar said the articles showed no association between use of the two classes of blood pressure drugs of concern and dying from COVID-19. “In fact, some studies suggest that these drugs might reduce lung injury in people infected with the novel virus,” he said. Dr Nisar said it is vitally important to keep your blood pressure well controlled and take medication as advised. “Having high blood pressure has been associated with higher rate of dying from Covid-19,” he said. “People should stick with their blood pressure medication because high blood pressure is a risk factor for heart attack, stroke and kidney failure,” said Dr Nisar –(KNO)

Trending

TOP STORIES1 hours ago

Delhi-Ladakh dialogue : GoI team to meet LAB, KDA leaders in Leh on July 2 | KNO

TOP STORIES1 hours ago

Srinagar logs season's second hottest day at 35.2°C; monsoon rains to bring relief | KNO

TOP STORIES1 hours ago

Govt announces 14-day summer break for Kashmir schools from July-06 | KNO

TOP STORIES5 hours ago

Summer break for Kashmir schools likely from July-06 | KNO

TOP STORIES5 hours ago

Summer break for Kashmir schools likely from July-06 | KNO

TOP STORIES9 hours ago

Mirwaiz urges India-Pak dialogue, calls for unity in Kashmir | KNO

TOP STORIES1 days ago

Amarnath Yatra: Multi-layer security grid in place from Punjab to J&K | KNO

TOP STORIES1 days ago

Every stakeholder devoted to ensuring safe, memorable Amarnath Yatra for pilgrims: LG Sinha | KNO

TOP STORIES1 days ago

Varmul Gindo 3.0: Sports helping youth reject drugs, divisive narratives: GOC Joshi | KNO

TOP STORIES1 days ago

J&K must create new exporters, diversify export basket to meet 2030 target: CM Omar | KNO

TOP STORIES1 days ago

‘Diversion of 197 ha of J&K Forest Land Approved for 820-MW Power Plant’ | KNO

TOP STORIES1 days ago

Srinagar sizzles at 35.3 C, city records season’s highest temperature | KNO

TOP STORIES1 days ago

J&K exports grow by 35% in Fy-2025-26: FIEO DG Ajay Sahai | KNO

TOP STORIES1 days ago

BLOs pillars of democracy: CEC Gyanesh Kumar | KNO

TOP STORIES1 days ago

‘International Buyer-Seller Meet’: Direct business deals to boost J&K’s handicrafts sector: CM’s Advisor Wani | KNO

TOP STORIES1 days ago

Amarnath Yatra: SOG, NSG hold joint anti-terror drill at Raghunath Mandir | KNO

TOP STORIES1 days ago

Gurez enters adventure tourism map with launch of 482 metre zipline | KNO

Copyright © 2021